Panacea Index Logo

Command Palette

Search for a command to run...

Effect of Bright Light Therapy on Depressive Symptoms in Middle-Aged and Older Patients Receiving Long-Term Hemodialysis.

International journal of environmental research and public health
January 1, 1970
Shu-Yi Huang et al. (5 authors)
Journal ArticleRandomized Controlled TrialHuman StudyClinical
Study Details

Study Goal

The researchers aimed to assess the effects of bright light therapy (BLT) on depressive symptoms among middle-aged and older adults receiving long-term hemodialysis.

Results Summary

The abstract does not provide specific results, but the study design suggests an evaluation of BLT's impact on depressive symptoms (measured by BDI-II scores) and salivary cortisol levels in hemodialysis patients.

Population

Middle-aged and older adults receiving long-term hemodialysis in eastern Taiwan.

Effective Dosage

30-minute sessions of BLT five times a week.

Duration

Six weeks.

Interactions

None mentioned.

Extracted Claims (3)
InterventionDirectionEndpointPopulationDosageImpactClaim #
bright light therapy (BLT)
neutral
depressive symptoms
middle-aged and older adults receiving long-term hemodialysis
-
assess the effects
#1
bright light therapy (BLT)
neutral
Beck Depression Inventory-II (BDI-II) scores
middle-aged and older adults receiving long-term hemodialysis
-
obtained
#2
bright light therapy (BLT)
neutral
salivary cortisol levels
middle-aged and older adults receiving long-term hemodialysis
-
obtained
#3
Abstract

Depressive symptoms are common psychiatric comorbidities among individuals receiving long-term hemodialysis. The aim of this two-arm parallel design study is to assess the effects of bright light therapy (BLT) on depressive symptoms among middle-aged and older adults receiving long-term hemodialysis. Study participants are recruited using convenient sampling from four dialysis clinics in eastern Taiwan. The eligible participants are block-randomized to either the BLT group (n = 30), with 30 min sessions of BLT five times a week for six weeks at their own home, or to the routine care control group (n = 30). The Beck Depression Inventory-II (BDI-II) scores and the salivary cortisol levels are obtained from the participants at three time points: baseline (T

Medical Subject Headings (MeSH)
AgedDepressionFemaleHumansMaleMiddle AgedPhototherapyRenal DialysisTaiwanTreatment Outcome
Study Links
Quality Scores
SafetyNot Assessed
Efficacy70/10
Quality75/10
Citation Metrics
Total Citations1
Citations/Year0.2
Relative Citation Ratio0.07
NIH Percentile3.7%
Research Impact Scores
APT Score0.05
Weight Score1.37
Normalized Score0.63
Related Supplements
Effect of Bright Light Therapy on Depressive Symptoms in Mid... | Panacea Index